Microbe transmitted between mosquitoes could be key to controlling malaria

NewsGuard 100/100 Score

A microbe that is transmitted between male and female mosquitoes but can also block reproduction could be key to controlling malaria by targeting its release into mosquito populations, a study says.

The study published in Frontiers in Microbiology found that the microbe called Microsporidia MB can pass from one mosquito to another as they mate. It could also block the release of malaria parasites from infected mosquitoes.

This finding is of major significance because it indicates that Microsporidia MB could be deployed as a tool to control malaria. However, for Microsporidia MB to be a viable tool, researchers will have to find a way to spread it into mosquito populations."

Jeremy Herren, co-author of the study and research scientist, International Centre of Insect Physiology (icipe), Kenya

Herren tells SciDev.Net that while increasing use of important malaria control tools such as bed nets have led to a major decline in malaria over the last 20 years, progress in fighting malaria is stagnating.

One reason for this is that mosquitoes are becoming resistant to insecticides commonly used in treated bed nets, underscoring the need to develop new complementary disease-control tools.

"This study is, therefore, an important step towards the development of a completely new and potentially transformative strategy to control malaria." Herren adds. "The burden of malaria presents a major challenge for development goals in Africa. Over 90 per cent of global malaria cases and deaths occur in Africa, which has enormous societal and economic consequences."

The study, which was conducted in 2019 through experiments on mosquitoes under laboratory conditions, involved the use of tools to determine whether or not individual mosquitoes have Microsporidia MB in them. Researchers also used a method called fluorescence microscopy to observe Microsporidia MB in the testes and ovaries of the mosquitoes.

According to Herren, the next step is to build on these findings to develop a viable strategy to spread Microsporidia MB through mosquito populations to control malaria transmission.

"We are exploring the feasibility ofreleasing male mosquitoes laden withMicrosporidia MBin areas of highmalaria transmission. These males would continue with their naturallife cycle, infecting wild female mosquitoes with the microbe, which wouldinturn infect their offspring with the malaria blocking trait," he says.

Brian Tarimo, a research scientist at the Ifakara Health Institute in Tanzania, says that the finding that the microbe is transmitted between mosquitoes of opposite sex during sexual reproduction makes it easy for this control intervention to spread throughout its population.

"This makes its deployment to the field much easier as it doesn't require human compliance or behavioural change. Furthermore, Microsporidia MB doesn't come along with a fitness cost in mosquitoes. This means that the chances of developing resistance against it is very slim to none," he tells SciDev.Net.

Adopting the microbe as a disease-control method, according to Tarimo, would be feasible but requires effective engagement with regulators, policymakers and community members.

He calls on health policymakers in malaria-endemic regions to invest in using the findings to create a novel tool to control malaria.

"Trends show that there is a plateau in the reduction of malaria cases while in some areas there is an increase. Therefore, novel control tools being developed … have to be seriously considered for addition into the control toolbox," he says.

Source:
Journal reference:

Nattoh, G., et al. (2021) Horizontal Transmission of the Symbiont Microsporidia MB in Anopheles arabiensis. Frontiers in Microbiology. doi.org/10.3389/fmicb.2021.647183.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show